You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:
Business Description: Unilife Corporation Limited (UNS, formerly Unilife Medical Solutions Limited) is US based developer and commercial supplier of injectable drug delivery systems. Its proprietary devices are designed be integrated into the filling and packaging processes for a target injectable drug or vaccine for pharmaceutical companies. UNS’s products are distributed in both Australia and overseas.
Strategy Analysis: UNS is focussed on the development, production and sale of safety syringes, the expansion of their global operational and commercial presence and, the establishment of long term supply relationships with multinational pharmaceutical and healthcare equipment companies.
Unilife Corporation reported a net loss of US$27.14m for the half-year ended 31 December 2012. Revenues from ordinary activities were US$1.4m, down 54.3% from the same period last year. Basic and Diluted EPS were (0.35) US cents compared to (0.35) US cents last year. The net operating cash outflow was US$20.74m compared to an outflow of US$18.76m in the pcp. No dividend was declared.
The Age 18/05/2013 |
As Australia's major retailers increase their online sales channels, pouring millions into their websites, they could face new competition from China's booming e-commerce industry.
The Age 18/05/2013 |
Most of those who take a political approach to the budget assume that if it's in deficit, the way you get it back to surplus is to cut government spending or, if you're a really bad person, increase taxes. They forget it's the budget itself that's supposed to do the heavy lifting.
Already a member? 
$ 0.590
